Navigation Links
Nonin Medical, Inc. Receives Frost & Sullivan's 2007 Award for Product Differentiation Innovation
Date:12/19/2007

MINNEAPOLIS, Dec. 19 /PRNewswire/ -- Nonin Medical, Inc., a leading innovator of physiological monitoring solutions, received the 2007 Industry Best Practices Award for Product Differentiation Innovation from Frost & Sullivan. Frost & Sullivan recognizes outstanding industry achievements and the Awards are recognized worldwide by the media, the investment community and end-user markets. The global growth consulting company honored Nonin for its pioneering vision that has transformed the vital sign monitoring industry and brought powerful, portable and easy-to-use pulse oximetry technology to more people and applications worldwide.

"Nonin's PureSAT(R) signal processing and PureLight(R) sensor technologies offer unparalleled blood oxygen saturation level recording and analysis by eliminating the effect of low perfusion and motion artifacts," said the Frost & Sullivan report. With its patented PureSAT technology built into every device, Nonin's robust technology delivers accurate performance in both acute care and alternate care environments.

With well over 1 million oximeters sold worldwide, "Nonin Medical has not only set new standards, but also released the untapped potential in a variety of markets," the report from Frost & Sullivan states. A number of Nonin's innovative "firsts" include the world's first self-contained fingertip oximeter, the first low power handheld oximeter and the first Bluetooth(R) Wireless Oximeter. Because of their accuracy, small size and portability, Nonin's oximeters have opened up a whole new direction in patient care in both acute care and alternate care markets.

As one of the Founding Promoters of the Continua Health Alliance(SM) and a member of the Bluetooth(R) SIG, Nonin has joined hands with some of the finest healthcare and technology companies to improve patient care. These organizations are committed to connecting technology and people through the facilitation of interoperable solutions and information exchange. CEO Gary Tschautscher, also recognized by Frost & Sullivan as CEO of 2007 in North American Patient Monitoring, adds, "We believe the future brings a streamlined environment that eliminates proprietary interfaces and facilitates interoperability with other medical equipment. Given the rise of chronic conditions and an aging population, Nonin is focusing on how patient care is evolving from traditional clinical settings to everyday environments, including the home." Nonin's vision for the future is to continue its leadership in offering a wide range of medical solutions to simplify patient care.

About Nonin Medical, Inc. - http://www.nonin.com

Minneapolis-based Nonin Medical, Inc., a privately owned company specializing in the design and manufacture of physiological monitoring solutions, distributes its branded and OEM products to health and medical professionals in more than 125 countries. Since 1986, Nonin has developed a broad product line of pulse oximeters, capnographs, sensors, accessories and software for use by medical professionals. Its industry-leading capabilities in signal processing, sensor design and an innovative combination of features not available in competitive products are the foundation of its leadership in innovation.

About Frost & Sullivan - http://www.frost.com

Frost & Sullivan, the Growth Consulting Company, partners with clients to accelerate their growth. The company's Growth Partnership Services, Growth Consulting and Career Best Practices empower clients to create a growth focused culture that generates, evaluates and implements effective growth strategies. Frost & Sullivan employs over 45 years of experience in partnering with Global 1000 companies, emerging businesses and the investment community from more than 30 offices on six continents. For more information about Frost & Sullivan's Growth Partnerships, visit http://www.awards.frost.com.


'/>"/>
SOURCE Nonin Medical, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. Masimo Launches Patient SafetyNet and Showcases the Rainbow SET Upgradable Noninvasive Monitoring Platform at 2007 ASA Annual Meeting
2. Tutogen Medical, Inc. to Present at the Roth Capital Partners 2007 New York Conference
3. Tutogen Medical, Inc. and Zimmer Holdings, Inc. Announce Agreement for International Distribution of Biological Products
4. Tutogen Medical, Inc. to Report Fourth Quarter and Fiscal Year 2007 Financial Results
5. Tutogen Medical, Inc. Reports Year-End Fiscal 2007 Financial Results
6. Reclast(R) Receives US FDA Approval as First and Only Once-Yearly Treatment for Women With Postmenopausal Osteoporosis
7. Ciphergen Biosystems Receives Noncompliance Letter From The Nasdaq Stock Market
8. Indevus Receives Approvable Letter From FDA for VALSTAR(R) for Bladder Cancer Therapy
9. Anesiva Receives FDA Approval for Zingo(TM), a New, Innovative Product to Reduce Pain Associated with Needle Insertion Procedures in Children
10. IsoTis Receives FDA Clearance for Accell Family of Products
11. Actavis Receives Approval of Fentanyl Transdermal System in the U.S.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... ... 2016 , ... UAS LifeSciences, one of the leading manufacturers ... Probiotics, into Target stores nationwide. The company, which has been manufacturing high quality ... list of well-respected retailers. This list includes such fine stores as Whole Foods, ...
(Date:6/23/2016)... 23, 2016 Houston Methodist Willowbrook Hospital ... Sports Association to serve as their official health ... Methodist Willowbrook will provide sponsorship support, athletic training ... association coaches, volunteers, athletes and families. ... Sports Association and to bring Houston Methodist quality ...
(Date:6/23/2016)... SAN FRANCISCO , June 23, 2016   ... it has secured $1 million in debt financing from ... to ramp up automation and to advance its drug ... for its new facility. "SVB has been ... goes beyond the services a traditional bank would provide," ...
(Date:6/23/2016)... , June 23, 2016 Apellis Pharmaceuticals, ... 1 clinical trials of its complement C3 inhibitor, ... and multiple ascending dose studies designed to assess ... of subcutaneous injection in healthy adult volunteers. ... either as a single dose (ranging from 45 ...
Breaking Biology Technology:
(Date:6/22/2016)... Md. , June 22, 2016  The American College ... Trade Show Executive Magazine as one of the ... on May 25-27 at the Bellagio in Las ... on the highest percentage of growth in each of the ... of exhibiting companies and number of attendees. The 2015 ACMG ...
(Date:6/22/2016)... , June 22, 2016 On Monday, ... call to industry to share solutions for the Biometric ... U.S. Customs and Border Protection (CBP), explains that CBP ... are departing the United States , ... and to defeat imposters. Logo - ...
(Date:6/20/2016)... , June 20, 2016 Securus ... justice technology solutions for public safety, investigation, corrections ... the prisons involved, it has secured the final ... (DOC) facilities for Managed Access Systems (MAS) installed. ... additional facilities to be installed by October, 2016. ...
Breaking Biology News(10 mins):